Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.
Barter
Philip J
PJ
The Heart Research Institute and the Department of Medicine, University of Sydney, Australia. barterp@hri.org.au
Rye
Kerry-Anne
KA
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications / Q000188:drug therapy; D009135:Muscular Diseases / Q000139:chemically induced; D004366:Nonprescription Drugs / Q000009:adverse effects* / Q000627:therapeutic use; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012651:Self Medication
D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D004366:Nonprescription Drugs